HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
2016 · Immunity · 435 citations
https://doi.org/10.1016/j.immuni.2016.08.016
G
Gabriel Ozorowski
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
194
Papers
10.4K
Citations
51
h-index
105
i10-index
Gabriel Ozorowski is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: HIV Research and Treatment & Monoclonal and Polyclonal Antibodies Research & Immune Cell Function and Interaction. The author has an h-index of 51, co-authored 165 publications.
ORCID: 0000-0002-9695-8138Papers by this author
worksFusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
2016 · Science · 369 citations
https://doi.org/10.1126/science.aae0474
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
2015 · Cell · 366 citations
https://doi.org/10.1016/j.cell.2015.11.056
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
2017 · Immunity · 327 citations
https://doi.org/10.1016/j.immuni.2017.05.007
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike
2017 · Nature · 263 citations
https://doi.org/10.1038/nature23010
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
2015 · Retrovirology · 187 citations
https://doi.org/10.1186/s12977-015-0210-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat